AKAM
50
2
UAL
73
3
AIV
39
6
NEM
30
2
V
70
14
GT
43
2
ITW
45
2
EXPE
83
8
TAP
57
6
STX
34
2
EQIX
59
2
RL
73
5
QRVO
16
-6
FOX
71
3
BXP
39
5
MSI
52
3
THC
52
9
NI
63
5
ABBV
40
5
KHC
11
2
AKAM
50
2
UAL
73
3
AIV
39
6
NEM
30
2
V
70
14
GT
43
2
ITW
45
2
EXPE
83
8
TAP
57
6
STX
34
2
EQIX
59
2
RL
73
5
QRVO
16
-6
FOX
71
3
BXP
39
5
MSI
52
3
THC
52
9
NI
63
5
ABBV
40
5
KHC
11
2
Financhill
Back

NLS Pharmaceutics Quote, Financials, Valuation and Earnings

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.
Sell
28

NLSP
NLS Pharmaceutics

Last Price:
$1.91
Seasonality Move:
0.34%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

NLS Pharmaceutics Price Quote

$1.91
-0.01 (-19.75%)
(Updated: December 21, 2024 at 5:39 AM ET)

NLS Pharmaceutics Key Stats

Sell
28
NLS Pharmaceutics (NLSP) is a Sell
Day range:
$1.78 - $2.29
52-week range:
$1.73 - $24.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
258K
Avg. volume:
375.7K
1-year change:
-89.45%
Market cap:
$7.3M
Revenue:
$0
EPS:
$-6.74

How Much Does NLS Pharmaceutics Make?

Data Unavailable

Is NLS Pharmaceutics Growing As A Company?

Data Unavailable

NLS Pharmaceutics Stock Price Performance

  • Did NLS Pharmaceutics Stock Go Up Last Month?
    NLS Pharmaceutics share price went down by -41.64% last month
  • Did NLSP's Share Price Rise Over The Last Year?
    NLSP share price fell by -89.45% over the past 1 year

What Is NLS Pharmaceutics 52-Week High & Low?

NLS Pharmaceutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NLS Pharmaceutics?

Data Unavailable

Is NLS Pharmaceutics Cash Flow Positive?

Data Unavailable

NLS Pharmaceutics Return On Invested Capital

Data Unavailable

NLS Pharmaceutics Earnings Date & Stock Price

NLS Pharmaceutics Competitors

  • Who Are NLS Pharmaceutics's Competitors?
    Below is a list of companies who compete with NLS Pharmaceutics or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)

NLS Pharmaceutics Dividend Yield

Data Unavailable

NLS Pharmaceutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable